InvestorsHub Logo
Followers 50
Posts 5118
Boards Moderated 0
Alias Born 02/05/2016

Re: biosectinvestor post# 592216

Wednesday, 05/10/2023 6:49:33 PM

Wednesday, May 10, 2023 6:49:33 PM

Post# of 705558
Commercial approval has zero impact on specials revenue. It wasnt/isn’t the bottleneck. That it just happened is irrelevant.

Revenue doubling maybe means they went from 2-3 patients in Q1 2022 to 3-5 patients in 2023. So no, there was no change. That is noise. People here are trying to claim we’ll see double digit units monthly prior to approval. It’s not happening.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News